QR Kodea

Nanomedicine Against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence

The accumulation of amyloid β (Aβ) triggers a cascade of toxic events in Alzheimer’s disease (AD). The KLVFF peptide can interfere with Aβ aggregation. However, the peptide suffers from poor bioavailability and the inability to cross the blood−brain barrier. In this work,...

Deskribapen osoa

Gorde:
Egile Nagusiak: Francesca Pederzoli, Barbara Ruozi, Jason Duskey, Simone Hagmeyer, Ann Katrin Sauer, Stefanie Grabrucker, Romina Coelho, Natalia Oddone, Ilaria Ottonelli, Eleonora Daini, Michele Zoli, Maria Angela Vandelli, Giovanni Tosi, Andreas M. Grabrucker
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI AG 2019-11-01
Saila:Pharmaceutics
Gaiak:
alzheimer disease (ad)
polymeric nanoparticles (nps)
klvff peptide
blood-brain barrier (bbb)
amyloid β
aβ
Sarrera elektronikoa:https://www.mdpi.com/1999-4923/11/11/572
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak